In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection
Abstract Pseudomonas aeruginosa is an opportunistic and frequently drug-resistant pulmonary pathogen especially in cystic fibrosis sufferers. Recently, the frog skin-derived antimicrobial peptide (AMP) Esc(1–21) and its diastereomer Esc(1–21)-1c were found to possess potent in vitro antipseudomonal...
Enregistré dans:
Auteurs principaux: | Chen Chen, Maria Luisa Mangoni, Y. Peter Di |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/68bccc7475c24d24b7ed3e1ce73fc79e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms
par: Trevor Beaudoin, et autres
Publié: (2018) -
CD69 mediates the protective role of adipose tissue‐derived mesenchymal stem cells against Pseudomonas aeruginosa pulmonary infection
par: Yanshan Jiang, et autres
Publié: (2021) -
The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
par: Emma Hennessy, et autres
Publié: (2014) -
Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
<i>In Vitro</i>
and
<i>In Vivo</i>
par: Dina A. Moustafa, et autres
Publié: (2021) -
Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes.
par: Adrianne Enos, et autres
Publié: (2021)